About Wagnerhuber Pharmaceuticals Private Limited
Data last updated:
Wagnerhuber Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 April 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2010PTC032148. Its GSTIN is 04AAACW9508N1ZY (Chandigarh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Virender Kumar (Whole-Time Director) and Ashwani Bhalla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S.C.O. 165 Sector 38 C&D, Chandigarh, India – 160036.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.36 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹8.41 Lakh (net margin 3.6%) and EBITDA of ₹11.89 Lakh (EBITDA margin 5%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 3% over five years.
The company has about 4 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website wagnerhuber.in.
Company details
Contact details
Wagnerhuber Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its website is wagnerhuber.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS.C.O. 165 Sector 38 C&D, Chandigarh, India – 160036
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wagnerhuber Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Wagnerhuber Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Wagnerhuber Pharmaceuticals Private Limited, buy the company report.
Financials of Wagnerhuber Pharmaceuticals Private Limited
FY 2025 filings availableWagnerhuber Pharmaceuticals Private Limited reported revenue of ₹2.36 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 8% fall in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8.41 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wagnerhuber Pharmaceuticals Private Limited, buy the company report.
Board of directors of Wagnerhuber Pharmaceuticals Private Limited
Wagnerhuber Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwani Bhalla | Director | 12 Apr 2010 | 16 Years 6 Months | Current |
| Virender Kumar | Whole-Time Director | 28 Mar 2018 | 8 Years 7 Months | Current |
| Sumit Kumar | Director | 01 Nov 2019 | 6 Years 11 Months | Current |
Peer comparison
Wagnerhuber Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Levin Formulations Private Limited | ₹2.36 Cr (FY 2025) | -13.0% | Hyderabad, Telangana, India | |||
| Wagnerhuber Pharmaceuticals Private Limitedthis company | ₹2.36 Cr (FY 2025) | ₹8.41 Lakh | 3.6% | -8.0% | 4 | Chandigarh, India |
| Newmet Pharmaceuticals Private Limited | ₹2.36 Cr (FY 2025) | 11.0% | Ghaziabad, Uttar Pradesh, India | |||
| Zupisure Formulations Private Limited | ₹2.36 Cr (FY 2025) | 35.0% | Mumbai, Maharashtra, India | |||
| Famy Life Sciences Private Limited | ₹2.36 Cr (FY 2025) | 9.0% | Hyderabad, Telangana, India | |||
| Arka Vital Science Private Limited | ₹2.36 Cr (FY 2025) | 22.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Wagnerhuber Pharmaceuticals Private Limited, buy the company report.
Auditor
Wagnerhuber Pharmaceuticals Private Limited is audited by MGSG & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MGSG & ASSOCIATES | FY 2022 | 033841N |
Shareholding
The shareholding of Wagnerhuber Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Wagnerhuber Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wagnerhuber Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wagnerhuber Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Wagnerhuber Pharmaceuticals Private Limited has a workforce of 4 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
GST
Wagnerhuber Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAACW9508N1ZY | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Wagnerhuber Pharmaceuticals Private Limited, buy the company report.
Recent activity
Wagnerhuber Pharmaceuticals Private Limited has 9 board changes on record since 2010: 6 appointments and 3 cessations. The latest: Keshav Kumar ceased to be Director on 20 Mar 2021.
Frequently asked questions
Wagnerhuber Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 April 2010 (16+ years old) and is registered under CIN U24232CH2010PTC032148.
Wagnerhuber Pharmaceuticals has 3 current directors:
- Virender Kumar - Whole-Time Director
- Ashwani Bhalla - Director
- Sumit Kumar - Director
The latest financial statements of Wagnerhuber Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Wagnerhuber Pharmaceuticals is 04AAACW9508N1ZY, registered in Chandigarh.
The CIN (Corporate Identification Number) of Wagnerhuber Pharmaceuticals is U24232CH2010PTC032148. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wagnerhuber Pharmaceuticals was incorporated on 12 April 2010, making it 16+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Wagnerhuber Pharmaceuticals by revenue are Levin Formulations Private Limited, Newmet Pharmaceuticals Private Limited, Zupisure Formulations Private Limited, Famy Life Sciences Private Limited, Arka Vital Science Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Keshav Kumar ceased to be Director on 20 Mar 2021. Keshav Kumar was appointed as Director on 01 Nov 2019. Sumit Kumar was appointed as Director on 01 Nov 2019. Wagnerhuber Pharmaceuticals has 9 board changes on record in total.
Wagnerhuber Pharmaceuticals can be reached through the website wagnerhuber.in. Its registered office is in Chandigarh, India.
The registered office of Wagnerhuber Pharmaceuticals is at S.C.O. 165 Sector 38 C&D, Chandigarh, India – 160036.
Wagnerhuber Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
